Year archive

MBB SE — 2025 filings

All 53 regulatory filings released by MBB SE (MBB) in 2025, sourced directly from the official regulator.

53 Filings

2025 Period

2025 filings (53)

Filing	Released	Lang
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-12-28	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-12-20	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-12-15	English
MBB SE resolves share buyback with a maximum volume of 22 million up to 222 per share Transaction in Own Shares	2025-12-09	English
Q3 statement / Q3 financial report 2025 Interim / Quarterly Report 9M 2025	2025-11-18	English
MBB SE increases EBITDA by 80% to 67.4 million in the third quarter and raises its forecast to 1.1-1.2 billion in revenue with an EBITDA margin of 15-17% Earnings Release 9M 2025	2025-10-21	English
MBB SE increases EBITDA by 37% in first half-year and confirms upper end of forecast range Earnings Release H1 2025	2025-08-14	English
Half-yearly financial report 2025 Interim / Quarterly Report H1 2025	2025-08-14	English
Report Publication Announcement 2025 Report Publication Announcement	2025-08-05	English
MBB SE: Anton Breitkopf, sell Director's Dealing	2025-07-30	English
MBB SE increases EBITDA by 37% in the first half-year and expects to achieve forecast range at the upper end Earnings Release H1 2025	2025-07-23	English
MBB SE grows revenues by 27% to 260 million and increases EBITDA by 32% in the first quarter Earnings Release Q1 2025	2025-05-13	English
Q1 statement / Q1 financial report 2025 Interim / Quarterly Report Q1 2025	2025-05-13	English
MBB SE: Bekanntmachung der Einberufung zur Hauptversammlung am 17.06.2025 in Berlin mit dem Ziel der europaweiten Verbreitung gema 121 AktG AGM Information	2025-05-09	German
MBB SE is promoted to the SDAX Regulatory Filings	2025-05-07	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-05-01	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-04-18	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-04-11	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-04-04	English
MBB SE: Dr. Jakob Ammer, sell Director's Dealing	2025-04-02	English
MBB SE achieves record revenue of 1,068 million with an EBITDA margin of 14% in 2024 Earnings Release FY 2024	2025-03-31	English
Annual financial report 2024 Annual Report FY 2024	2025-03-31	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-03-28	English
MBB SE proposes 15th consecutive base dividend increase to 1.11 and anniversary dividend of 2.22 Notice of Dividend Amount	2025-03-27	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-03-21	English
MBB SE adjusts share buyback program 2024/II and buys shares up to a price of 150.00 Transaction in Own Shares	2025-03-21	English
MBB SE adjusts share buyback program 2024/II and buys shares up to a price of 150.00 Transaction in Own Shares	2025-03-20	English
Report Publication Announcement 2025 Report Publication Announcement	2025-03-20	English
Report Publication Announcement 2025 Report Publication Announcement	2025-03-19	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-03-14	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-03-11	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-03-10	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-03-03	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-03-02	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-02-22	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-02-21	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-02-15	English
Bekanntmachung gema Art. 5 Abs. 1 lit. b) und Abs. 3 der Verordnung (EU) Nr. 596/2014 i. V. m. Art. 2 Abs. 2 und Abs. 3 der Delegierten Verordnung (EU) Nr. 2016/1052 Transaction in Own Shares	2025-02-14	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-02-07	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-01-31	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-01-28	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-01-27	English
MBB SE: Dr. Jakob Ammer, sell Director's Dealing	2025-01-21	English
MBB SE: Dr. Jakob Ammer, sell Director's Dealing	2025-01-20	English
MBB SE: Dr. Jakob Ammer, sell Director's Dealing	2025-01-20	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-01-18	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-01-17	English
MBB beats its 2024 guidance with revenues of 1.06 billion at an EBITDA margin of more than 13% based on preliminary figures and announces management changes Earnings Release FY 2024	2025-01-17	English
MBB beats its 2024 guidance with revenues of 1.06 billion at an EBITDA margin of more than 13% based on preliminary figures and announces management changes Earnings Release FY 2024	2025-01-16	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-01-11	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201 Transaction in Own Shares	2025-01-10	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulat Transaction in Own Shares	2025-01-06	English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulat Transaction in Own Shares	2025-01-05	English

Filings by year

2026 25 filings
2025 53 filings
2024 34 filings
2023 32 filings
2022 37 filings
2021 55 filings
2020 30 filings
2019 34 filings
2018 18 filings
2017 23 filings
2016 12 filings
2015 16 filings
2014 19 filings
2013 27 filings
2012 20 filings
2011 19 filings
2010 9 filings
2009 17 filings
2008 21 filings
2007 13 filings
2006 10 filings